These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11516276)

  • 1. Synthesis and catalytic antibody functionalization of dendrimers.
    Córdova A; Janda KD
    J Am Chem Soc; 2001 Aug; 123(34):8248-59. PubMed ID: 11516276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy.
    Rader C; Turner JM; Heine A; Shabat D; Sinha SC; Wilson IA; Lerner RA; Barbas CF
    J Mol Biol; 2003 Sep; 332(4):889-99. PubMed ID: 12972259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2.
    Shamis M; Lode HN; Shabat D
    J Am Chem Soc; 2004 Feb; 126(6):1726-31. PubMed ID: 14871103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Polyester Dendritic Scaffolds for Biomedical Applications.
    Sadowski LP; Edem PE; Valliant JF; Adronov A
    Macromol Biosci; 2016 Oct; 16(10):1475-1484. PubMed ID: 27376967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational elucidation and validation of the three-dimensional structure of humanized aldolase catalytic antibody 38C2.
    Jayakody RS; Jasin Arachchige LI; Japahuge A
    J Biomol Struct Dyn; 2021 Apr; 39(7):2463-2477. PubMed ID: 32242499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualizing antibody-catalyzed retro-aldol-retro-Michael reactions.
    Tanaka F; Kerwin L; Kubitz D; Lerner RA; Barbas CF
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2983-6. PubMed ID: 11677141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective aldol cyclodehydrations catalyzed by antibody 38C2.
    List B; Lerner RA; Barbas CF
    Org Lett; 1999 Jul; 1(1):59-61. PubMed ID: 10822533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity.
    Shamis M; Barbas CF; Shabat D
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1172-5. PubMed ID: 17234408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and esterolytic activity of catalytic peptide dendrimers.
    Lagnoux D; Delort E; Douat-Casassus C; Esposito A; Reymond JL
    Chemistry; 2004 Mar; 10(5):1215-26. PubMed ID: 15007811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate-selective mechanisms in biocatalysis demonstrated with a versatile and efficient aldolase antibody.
    Shulman H; Keinan E
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1745-50. PubMed ID: 10406635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic Enantioselective Retro-Aldol Reactions: Kinetic Resolution of β-Hydroxyketones with Aldolase Antibodies.
    Zhong G; Shabat D; List B; Anderson J; Sinha SC; Lerner RA; Barbas Iii CF
    Angew Chem Int Ed Engl; 1998 Oct; 37(18):2481-2484. PubMed ID: 29711357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation.
    Abraham S; Guo F; Li LS; Rader C; Liu C; Barbas CF; Lerner RA; Sinha SC
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5584-9. PubMed ID: 17372220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(α-hydroxy acid)s and poly(α-hydroxy acid-co-α-amino acid)s derived from amino acid.
    Basu A; Kunduru KR; Katzhendler J; Domb AJ
    Adv Drug Deliv Rev; 2016 Dec; 107():82-96. PubMed ID: 27527666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaction properties of catalytic antibodies encapsulated in organo substituted SiO2 sol-gel materials.
    Kato K; Saito T; Seelan S; Tomita M; Yokogawa Y
    J Biosci Bioeng; 2005 Oct; 100(4):478-80. PubMed ID: 16310742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of functionalized biodegradable polyesters.
    Williams CK
    Chem Soc Rev; 2007 Oct; 36(10):1573-80. PubMed ID: 17721582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cofactor approach to copper-dependent catalytic antibodies.
    Nicholas KM; Wentworth P; Harwig CW; Wentworth AD; Shafton A; Janda KD
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2648-53. PubMed ID: 11880619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-catalyzed decarboxylation and aldol reactions using a primary amine molecule as a functionalized small nonprotein component.
    Ishikawa F; Uno K; Nishikawa M; Tsumuraya T; Fujii I
    Bioorg Med Chem; 2013 Nov; 21(22):7011-7. PubMed ID: 24094435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple catalytic aldolase antibodies suitable for chemical programming.
    Goswami RK; Huang ZZ; Forsyth JS; Felding-Habermann B; Sinha SC
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3821-4. PubMed ID: 19428247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.
    Shabat D; Lode HN; Pertl U; Reisfeld RA; Rader C; Lerner RA; Barbas CF
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7528-33. PubMed ID: 11404472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the synthetic utility of aldolase antibody 38C2.
    Mondal K; Ramesh NG; Roy I; Gupta MN
    Bioorg Med Chem Lett; 2006 Feb; 16(4):807-10. PubMed ID: 16321532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.